Aller au contenu

Home
Project
About THROMBOTAX
Partners
Newsroom

Menu

Home
Project
About THROMBOTAX
Partners
Newsroom

ATVB

Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent.

NextApmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR
(French National Research Agency)Suivant

UMR CNRS 7369 MEDyC

Bâtiment 18, UFR Sciences Exactes et Naturelles, BP 1039, 51687 Reims Cedex 2, France

INSERM UMRS 1116

Faculté de Médecine, 9 avenue de la Forêt de Haye, CS 50184, 54505 Vandoeuvre Les Nancy Cedex

Apmonia Therapeutics

2 Rue Léon Patoux,
51100 Reims, France

I authorize this site to keep my data transmitted via this form

Creation : CHAMPAGNE CRÉATION – All rights reserved

Retour en haut